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Abstract
With the development of high-throughput sequencing and genotyping technologies, the number of markers collected in
genetic association studies is growing rapidly, increasing the importance of methods for correcting for multiple hypothesis
testing. The permutation test is widely considered the gold standard for accurate multiple testing correction, but it is often
computationally impractical for these large datasets. Recently, several studies proposed efficient alternative approaches to the
permutation test based on the multivariate normal distribution (MVN). However, they cannot accurately correct for multiple
testing in genome-wide association studies for two reasons. First, these methods require partitioning of the genome into
many disjoint blocks and ignore all correlations between markers from different blocks. Second, the true null distribution of
the test statistic often fails to follow the asymptotic distribution at the tails of the distribution. We propose an accurate and
efficient method for multiple testing correction in genome-wide association studies—SLIDE. Our method accounts for all
correlation within a sliding window and corrects for the departure of the true null distribution of the statistic from the
asymptotic distribution. In simulations using the Wellcome Trust Case Control Consortium data, the error rate of SLIDE’s
corrected p-values is more than 20 times smaller than the error rate of the previous MVN-based methods’ corrected p-values,
while SLIDE is orders of magnitude faster than the permutation test and other competing methods. We also extend the MVN
framework to the problem of estimating the statistical power of an association study with correlated markers and propose an
efficient and accurate power estimation method SLIP. SLIP and SLIDE are available at http://slide.cs.ucla.edu.
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Introduction
Association studies have emerged as a powerful tool for
discovering the genetic basis of human diseases [1–3]. With the
development of sequencing and high-throughput genotyping
technologies, the number of single nucleotide polymorphism
(SNP) markers genotyped by current association studies is
dramatically increasing. The large number of correlated markers
brings to the forefront the multiple hypothesis testing correction
problem and has motivated much recent activity to address it [4–6].
There are two common versions of the multiple testing
correction problem: per-marker threshold estimation and p-value
correction. In a typical study which collects M markers, at each
marker, we perform a statistical test and obtain a p-value which we
refer to as a pointwise p-value. We would like to know how significant
a pointwise p-value needs to be in order to obtain a significant
result given that we are observing M markers. The per-marker
threshold can be defined as the threshold for pointwise p-values
which controls the probability of one or more false positives [6].
Similarly, we would like to quantitatively measure the significance
of a pointwise p-value taking into account that we are observing M
markers. For each pointwise p-value, the corrected p-value can be
defined as the probability that, under the null hypothesis, a p-value
equal to or smaller than the pointwise p-value will be observed at
any marker [7]. For example, the Bonferroni correction corrects a
pointwise p-value p to pM, or estimates the per-marker threshold
as a=M given a significance threshold a.
While the Bonferroni (or S ˇida ´k) correction provides the simplest
way to correct for multiple testing by assuming independence
between markers, permutation testing is widely considered the
gold standard for accurately correcting for multiple testing [7].
However, permutation is often computationally intensive for large
data sets [4]. For example, running 1 million permutations for a
dataset of 500,000 SNPs over 5,000 samples takes up to 4 CPU
years using widely used software such as PLINK [8] (See Results).
On the other hand, the Bonferroni (or S ˇida ´k) correction ignores
correlation between markers and leads to an overly conservative
correction, which is exacerbated as the marker density increases.
In this paper, we correct for multiple testing using the
framework of the multivariate normal distribution (MVN). For
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markers asymptotically follow a MVN [9,10]. Using this
observation, several recent studies [4,9,10] proposed efficient
alternative approaches to the permutation test, and showed that
they are as accurate as the permutation test for small regions at the
size of candidate gene studies (with ,1% average error in
corrected p-values) [4]. However, when applied to genome-wide
datasets, they are not as accurate. In our analysis of the Wellcome
Trust Case Control Consortium (WTCCC) data [11], these
methods eliminate only two-thirds of the error in the corrected p-
values relative to the Bonferroni correction. There are two main
reasons why these methods do not eliminate all of the error. First,
the previous MVN-based methods can be extended to genome-
wide analyses only by partitioning the genome into small linkage
disequilibrium (LD) blocks and assuming markers in different
blocks are independent, because they can handle only up to
hundreds of markers in practice [4,9]. This block-wise strategy
leads to conservative estimates because inter-block correlations are
ignored (Figure 1B). Second, these methods do not account for the
previously unrecognized phenomenon that the true null distribu-
tion of a test statistic often fails to follow the asymptotic
distribution at the extreme tails of the distribution, even with
thousands of samples.
We propose a method for multiple testing correction called
SLIDE (a Sliding-window approach for Locally Inter-correlated
markers with asymptotic Distribution Errors corrected), which
differs from previous methods in two aspects. First, SLIDE uses a
sliding-window approach instead of the block-wise strategy.
SLIDE approximates the correlation matrix as a band matrix (a
matrix with non-zero elements along the diagonal band), which
can effectively characterize the overall correlation structure
between markers given a sufficiently large bandwidth. Then
SLIDE uses a sliding-window Monte-Carlo approach which
samples a statistic at each marker by conditioning on the statistics
at previous markers within the window, accounting for entire
correlation in the band matrix (Figure 1C).
Second, SLIDE takes into account the phenomenon that the
true null distribution of a test statistic often fails to follow the
asymptotic distribution at the tails of the distribution. It is well
known that if the sample size is small, the true distribution and the
asymptotic distribution show a discrepancy [12,13]. However, to
the best of our knowledge, the effect of this discrepancy in the
context of association studies has not been recognized, since
thousands of samples are typically not considered a small sample.
We observe that this discrepancy often appears in genome-wide
association studies, even with thousands of samples, because of the
extremely small genome-wide per-marker threshold (or pointwise
p-value). The error caused by this discrepancy is more serious for
datasets with a large number of rare variants, highlighting the
importance of this problem for association studies based on next-
generation sequencing technologies (See Materials and Methods).
SLIDE corrects for this error by scaling the asymptotic distribution
to fit to the true distribution.
With these two advances, SLIDE is as accurate as the
permutation test. In our simulation using the WTCCC dataset
[11], the error rate of SLIDE’s corrected p-values is more than 20
times smaller than the error rate of previous MVN-based methods’
corrected p-values, and 80 times smaller than the error rate of the
Bonferroni-corrected p-values. Our simulation using the 2.7
million HapMap SNPs [14] shows that SLIDE is accurate for
higher-density marker datasets as well. In contrast, the error rates
of previous MVN-based methods increase with the marker density,
since the dataset will include more rare variants. Computationally,
our simulation shows that SLIDE is orders of magnitude faster
than the permutation test and faster than other competing
methods.
Figure 1. Block-wise strategy and sliding-window approach. (A) Correlations between 10 markers are depicted. (B) Correlations taken into
account by a block-wise strategy with a block size of 5. The ignored correlations are shown as black. (C) Correlations taken into account by a sliding-
window approach with a window size of 5. The ignored correlations are shown as black.
doi:10.1371/journal.pgen.1000456.g001
Author Summary
In genome-wide association studies, it is important to
account for the fact that a large number of genetic variants
are tested in order to adequately control for false positives.
The simplest way to correct for multiple hypothesis testing
is the Bonferroni correction, which multiplies the p-values
by the number of markers assuming the markers are
independent. Since the markers are correlated due to
linkage disequilibrium, this approach leads to a conserva-
tive estimate of false positives, thus adversely affecting
statistical power. The permutation test is considered the
gold standard for accurate multiple testing correction, but
is often computationally impractical for large association
studies. We propose a method that efficiently and
accurately corrects for multiple hypotheses in genome-
wide association studies by fully accounting for the local
correlation structure between markers. Our method also
corrects for the departure of the true distribution of test
statistics from the asymptotic distribution, which dramat-
ically improves the accuracy, particularly when many rare
variants are included in the tests. Our method shows a
near identical accuracy to permutation and shows greater
computational efficiency than previously suggested meth-
ods. We also provide a method to accurately and efficiently
estimate the statistical power of genome-wide association
studies.
Multiple Testing Correction for Correlated Markers
PLoS Genetics | www.plosgenetics.org 2 April 2009 | Volume 5 | Issue 4 | e1000456The MVN framework for multiple testing correction is very
general, allowing it to be applied to many different contexts such
as quantitative trait mapping or multiple disease models [4]. We
show that the MVN framework can also correct for multiple
testing for the weighted haplotype test [15,16] and the test for
imputed genotypes based on the posterior probabilities [17].
In addition to multiple testing correction, we extend the MVN
framework to solve the problem of estimating the statistical power of
an association study with correlated markers. There are two
traditional approaches to this problem: a simulation approach
constructing case/control panels from the reference dataset
[4,10,17,18], which is widely considered the standard but is
computationally intensive; and the best-tag Bonferroni method
[19–21], which is an efficient approximation but is often inaccurate.
The power estimation problem can be solved within the MVN
framework because the test statistic under the alternative
hypothesis follows a MVN centered at the non-centrality
parameters (NCP). The vector of the NCPs turns out to be
approximately proportional to the vector of correlation coefficients
(r) between the causal SNP and the markers. This is a multi-
marker generalization of the Pritchard and Preworzki [22] single-
marker derivation of the NCP proportional to r. Our method
SLIP (Sliding-window approach for Locally Inter-correlated
markers for Power estimation) efficiently estimates a study’s power
using the MVN framework.
Seaman and Mu ¨ller-Myhsok [9] and Lin [10] pioneered the use
of the MVN for multiple testing correction. Seaman and Mu ¨ller-
Myhsok described the direct simulation approach (DSA) method.
Conneely and Boehnke [4] increased its efficiency by adapting an
available software package called mvtnorm [23,24]. Both studies
primarily focused on datasets used in candidate gene studies and
suggested the block-wise strategy as a possible approach for
genome-wide studies.
Another approach for multiple testing correction is to estimate
the effective number of tests from eigenvalues of the correlation
matrix [25–27]. Recently, Moskvina and Schmidt [6] and Pe’er et
al. [28] showed that the effective number of tests varies by the p-
value levels, demonstrating that a method estimating a constant
effective number can be inaccurate. Moskvina and Schmidt [6]
proposed a pairwise correlation-based method called Keffective,
which estimates the effective number taking into account the
significance level. Keffective is a sliding-window approach similar
to SLIDE, but it differs because within each window it uses the
pairwise correlation to the most correlated marker, while SLIDE
uses the conditional distribution given all markers. Fitting the
minimum p-value distribution by a beta distribution [29] has been
shown often to be inaccurate [6]. Kimmel and Shamir [30]
developed an importance sampling procedure called rapid
association test (RAT). RAT is efficient for correcting very
significant p-values, but requires phased haplotype data.
Connecting the multiple testing correction and power estima-
tion problems leads to the insight that the per-marker threshold
estimated from the reference dataset for estimating power can be
used as a precomputed approximation to the true per-marker
threshold for the collected samples. In simulations using the
WTCCC control data, we show that the per-marker threshold
estimated from the HapMap CEU population data approximately
controls the false positive rate.
Our methods SLIP and SLIDE require only summary statistics
such as the correlation between markers within the window size,
allele frequencies, and the number of individuals. Therefore unlike
the permutation test, our method can still be applied even if the
actual genotype data is not accessible. Our methods are available
at http://slide.cs.ucla.edu.
Materials and Methods
Multiple Testing Correction
Multivariate normal approximation. For many widely
used statistical tests, the vector of statistics over multiple markers
asymptotically follows a MVN [9,10]. The covariance matrix of
the MVN can be derived for many popular statistical tests such as
Armitage’s trend test in the context of the general score test [4,9].
We perform this derivation at the haplotype level using the
properties of the hypergeometric distribution in the context of the
x2 test in order to highlight the connection between the multiple
testing correction and the power estimation problems. In Text S1,
we also derive the covariance for the weighted haplotype test
[15,16] and the test for imputed genotypes [17,31,32]. All of the
results presented here for balanced case/control studies can be
extended to unbalanced studies. We will interchangeably use the
terms ‘covariance matrix’ and ‘correlation matrix’, because the
variances are 1.
Assume we permute N case haplotypes and N control
haplotypes. Let pi be the minor allele frequency (MAF) at marker
mi estimated from the sample. Let ^ p pz
i and ^ p p{
i be the observed
MAFs in the permuted case and control haplotypes. Although pi
itself is an observed value from the sample, we will consider it as a
constant because it is invariant over random permutations. The
minor allele count in the permuted case haplotypes, N^ p pz
i , follows
a hypergeometric distribution. If N is large, the test statistic at mi
Si~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2N{1
4
r
^ p pz
i {^ p p{
i ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pi 1{pi ðÞ
p *N 0,1 ðÞ :
The squared statistic differs from the Pearson’s x2 statistic by a
constant 2N{1
2N .
Let Si and Sj be the statistics at marker mi and mj. Let pij, pIj,
piJ, pIJ be the sample frequencies of the four haplotypes with
minor and major alleles at mi and mj respectively. A random
permutation is equivalent to selecting N case haplotypes from 4
bins of different haplotypes. Thus, the haplotype count in the
permuted case haplotypes, (N^ p pz
ij , N^ p pz
Ij , N^ p pz
iJ , N^ p pz
IJ), follows a
multivariate hypergeometric distribution. By the properties of the
hypergeometric distribution,
Cov ^ p pz
i ,^ p pz
j
  
~Cov ^ p pz
ij z^ p pz
iJ ,^ p pz
ij z^ p pz
Ij
  
~
1
2N{1
pij 1{pij
  
{piJpij{pijpIj{piJpIj
  
~
1
2N{1
pij{pipj
  
Cov ^ p pz
i {^ p p{
i ,^ p pz
j {^ p p{
j
  
~Cov ^ p pz
i { 2pi{^ p pz
i
  
,^ p pz
j { 2pi{^ p pz
j
     
~4Cov ^ p pz
i ,^ p pz
j
  
ð1Þ
Cov Si,Sj
  
~
pij{pipj ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pi 1{pi ðÞ pj 1{pj
   q ~rij ð2Þ
where rij is the correlation coefficient between mi and mj
measured in the sample.
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be the M|M covariance matrix between M
markers. By the multivariate central limit theorem [33], if N is
large, the vector of statistics S~ S1,...,SM ðÞ asymptotically
follows a MVN with mean zero and variance S. Given a
pointwise p-value u, let Ru ðÞbe the M-dimensional rectangle
with corners W{1 u=2 ðÞ 1M and W{1 1{u=2 ðÞ 1M where W is the
cumulative density function (c.d.f.) of the standard normal
distribution and 1M is the vector of M ones. The corrected p-
value u’ is approximated as the outside-rectangle probability,
u’~1{
1
2p ðÞ
M
2 S jj
1
2
ð
Ru ðÞ
e{1
2XTS{1XdX, ð3Þ
as shown in Figure 2A. Similarly, given a significance threshold a,
the per-marker threshold am is approximated by searching for a
pointwise p-value whose corrected p-value is a.
Discrepancy between asymptotic and true distribu-
tions. If the asymptotic MVN closely approximates the true
distribution of the statistic, then Formula (3) will provide an
accurate multiple testing correction; this has been shown to be true
for small regions such as those tested in candidate gene studies [4].
One may expect that the discrepancy between the asymptotic and
true distributions would be negligible in current association
studies, given their thousands of samples.
However, we observe that this discrepancy can appear in
genome-wide association studies, in spite of the large sample size,
because of the extremely small per-marker threshold (or pointwise
p-value) caused by the large number of tests. At its extreme tails,
the asymptotic distribution is typically thicker than the true
distribution.
This phenomenon can be illustrated with a single-SNP
experiment using the x2 test. For a threshold t, the asymptotically
approximated p-value (asymptotic p-value) is pasym~2W {
ﬃﬃ
t
p   
.
Assume 1,000 case and 1,000 control haplotypes. Given a fixed
number of minor alleles, we can list every possible 262 table. The
true p-value ptrue is the sum of the probabilities of the tables whose
statistic is §t. If the asymptotic approximation is accurate, then
pasym~ptrue. We compare these two p-values for many different
thresholds and plot the ratio in Figure 3. We repeat the
experiments for various MAFs and sample sizes.
Figure 3 shows that even with thousands of samples, at the
genome-wide significance level, the asymptotic p-value is highly
inflated compared to the true p-value. The inflation is more
dramatic for SNPs with small MAFs. We observe the similar
phenomenon using genotypes and the trend test (data not shown).
One may argue that this phenomenon is not important because
it mostly occurs at rare SNPs (MAF#5%) where current studies
already have low power to detect associations. However, an
incorrect approximation of the distributions at some SNPs affects
the corrected p-values of all SNPs. This is because the corrected p-
value depends on the distributions of the statistics at all of the
SNPs, as it is defined as the probability observing significant results
at any marker. For example, suppose we approximate 10
independent normal distributions at 10 independent SNPs.
Assume that we correctly approximate 9 distributions, but for
one distribution we think that the tails are thicker than the true
distribution by a factor of 100. For any given pointwise p-value p,
the true corrected p-value is 1{ 1{p ðÞ
10&10p by the S ˇida ´k
correction. However, we will estimate the corrected p-value as
1{ 1{p ðÞ
9 1{100p ðÞ &101p by integrating over the MVN. This
shows that incorrectly approximating the distributions at rare
SNPs can adversely affect the corrected p-values of all SNPs,
including common SNPs.
One can avoid this type of error in corrected p-values by using a
method not dependent on the asymptotic approximation, such as
the permutation test, or by eliminating rare SNPs in the analysis. It
may be sensible to remove rare SNPs with a few or tens of minor
allele counts, if the power is very low or if the SNPs are error-
prone in their calling. However, Figure 3 shows that the error
caused by using the asymptotic approximation happens even at
SNPs with minor allele counts in the hundreds. Therefore
removing all of them will decrease our power to detect
associations.
SLIDE. SLIDE corrects for multiple testing by using a sliding-
window approach to approximate the MVN and then scaling the
MVN to approximate the true distribution of the statistic. There
are two underlying intuitions. First, a sliding window approach
takes into account most of the correlations in the data due to the
local LD structure. Second, even though the asymptotic MVN
shows a departure from the true distribution at the tail, the scaled
MVN will closely approximate the true distribution because the
covariance between the statistics is identical in both the true
distribution and the MVN. (The covariance derivation does not
involve the central limit theorem.)
Step 1 — SLIDE first approximates the MVN by using a
sliding-window Monte-Carlo approach. Given M markers, let
(S1,   ,SM) be the vector of statistics which asymptotically follows
a MVN under the null hypothesis. Let fS 1,S2,   ,SM ðÞ be the
joint probability density function (p.d.f.) of the statistics. Our goal
is to generate a large number of samples, (^ S S1,^ S S2,   ,^ S SM), to
approximate the MVN. If M is very large, the standard sampling
Figure 2. Probability density function of a bivariate MVN at
two markers. The area outside the rectangle is the critical region. (A)
Under the null hypothesis, the MVN is centered at zero. The outside-
rectangle probability is the corrected p-value (or the significance level).
(B) Under the alternative hypothesis, the MVN is shifted by the non-
centrality parameter. The outside-rectangle probability is power.
doi:10.1371/journal.pgen.1000456.g002
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unless we split the region into small blocks.
Under the local LD assumption, the statistics at distant markers
are uncorrelated. Thus, given a window size w, we can assume
that Si is conditionally independent of S1,S2,   ,Si{w{1 given
Si{w,Si{wz1,   ,Si{1. Then by the chain rule,
fS 1,S2,   ,SM ðÞ
~fS 1 ðÞ fS 2 S1 j ðÞ fS 3 S1, j S2 ð Þ   fS M SM{w, j    ,SM{1 ðÞ :
Thus, ^ S Si can be sampled given ^ S Si{w,   ,^ S Si{1, based on the
conditional distribution fS i Si{w, j    ,Si{1 ðÞ . The conditional
distributions are given by the standard formula for the MVN.
Thus we can efficiently generate a large number of samples. The
procedure is described in detail in Text S2.
Step 2 — We scale the approximated MVN to fit to the true
distribution of the statistic (Figure 4). The rationale for this step is
that, if we only consider the marginal distribution at each marker,
it is possible to analytically compute the true distribution by listing
all possible 262o r2 63 contingency tables [35]. This allows us to
directly compare the asymptotic distribution and the true
distribution, and to compute how much we should scale the
asymptotic distribution to fit to the true distribution.
The level of discrepancy between the asymptotic and true
distributions is large at the tails of the distribution compared to the
center. Thus, in order to scale the asymptotic distribution to fit to
the true distribution, we cannot multiply the entire distribution by
a single scaling factor, but must instead compute the scaling factor
for each different threshold.
Given a x2 threshold t, we compute the scaling factor as follows.
The asymptotic p-value is 21 {W
ﬃﬃ
t
p      
. Let X be a random
variable following the true discrete distribution of the x2 statistic.
The exact true p-value is ptrue~Pr X§t ðÞ . The scaling factor is
computed as
ﬃﬃ
t
p  
W{1 1{ptrue=2 ðÞ , because if we scale the
standard normal distribution by this factor, the asymptotic p-
value for the scaled distribution becomes exactly ptrue at the
Figure 3. Discrepancy between asymptotic p-value and true p-value in a single SNP experiment. Given a x2 threshold t, the asymptotic
p-value is 2W {
ﬃﬃ
t
p   
. The true p-value is obtained by listing all possible contingency tables. The number of individuals (N) denotes the number of
haplotypes, half control and half case.
doi:10.1371/journal.pgen.1000456.g003
Figure 4. SLIDE’s scaling procedure. The probability density
function of the asymptotic bivariate MVN is depicted as a grid. The
probability mass function of the true distribution is depicted as a
histogram. (A) The asymptotic distribution often shows a discrepancy
from the true distribution. (The discrepancy is exaggerated in this
figure.) (B) After scaling down the asymptotic distribution, the
discrepancy is removed.
doi:10.1371/journal.pgen.1000456.g004
Multiple Testing Correction for Correlated Markers
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value pmid~Pr Xwt ðÞ z 1
2Pr X~t ðÞ [35] instead of ptrue provides
a better approximation to the true distribution.
Note that, for unbalanced case/control studies, the level of
discrepancy is not symmetric at the upper and lower tails of the
normal distribution. Thus, we should compute the scaling factor
for each tail of the normal distribution separately.
Step 3 — Given the scaled MVN, p-values are corrected by
integrating over the outside of the rectangle as in Formula (3).
Power Estimation
Assumptions. A discussion of association study power
depends on many arbitrary assumptions. Though our framework
can be extended to other assumptions, in this paper, we adopt
those used in De Bakker et al. [18]: (1) The disease status is affected
by a single SNP. (2) The allele effect is multiplicative. (3) The
relative risk is known. (4) The phased reference dataset represents
the population.(5) All marker SNPs are in the reference dataset. (6)
All possible causal SNPs are in the reference dataset. (7) Each
possible causal SNP is equally likely to be causal.
For complex diseases, assumption (1) can still be applied if each
causal SNP marginally contributes to the risk. Assumptions (4) and
(5) can lead to an overestimation of power, especially if the
markers are chosen using the reference dataset [36]. Instead of
assumption (7), a non-uniform distribution can also be used [37].
Finally, we assume that the investigator has determined the
number of individuals in the study and the significance threshold.
Multivariate normal approximation. We extend the
MVN framework to the power estimation problem. Consider a
study design which defines markers and plans to collect N=2 case
and N=2 control diploid individuals. Let ph
i be the population
MAF at marker mi estimated from the reference dataset (‘h’
denoting the HapMap [14]). Let pz
i and p{
i be the MAFs in the
case and control populations.
Single marker — If marker mi is causal for a disease of
prevalence F with relative risk c, under the multiplicative model,
pz
i ~cph
i
 
c{1 ðÞ ph
i z1
  
and p{
i ~ ph
i {Fpz
i
    
1{F ðÞ : ð4Þ
The case/control study can be thought of as a procedure which
draws N chromosomes from the case population and N
chromosomes from the control population. Let ^ p pz
i and ^ p p{
i be
random variables denoting the observed MAFs in the collected
cases and controls. Let ^ p pi~ ^ p pz
i z^ p p{
i
    
2 and pi~ pz
i zp{
i
    
2.
Then, since each of N^ p pz
i and N^ p p{
i follows a binomial
distribution, if N is large, the test statistic at marker mi
Si~
^ p pz
i {^ p p{
i ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2=N
p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
^ p pi 1{^ p pi ðÞ
p *N li
ﬃﬃﬃﬃﬃ
N
p
,1
  
,
where
li
ﬃﬃﬃﬃﬃ
N
p
~
pz
i {p{
i
2pi 1{pi ðÞ
ﬃﬃﬃﬃﬃ
N
p
is the non-centrality parameter.
If the marker and the causal SNP are distinct (a condition called
indirect association), the NCP derivation changes. Suppose a SNP sc
is causal but we collect marker mi. If we put an imaginary marker
mc at SNP sc, we can compute the NCP at marker mc lc
ﬃﬃﬃﬃﬃ
N
p   
,
and compute the correlation coefficient between mi and mc from
the reference dataset (rh
ic). Pritchard and Preworzki [22] show that
the NCP at marker i is approximately rh
iclc
ﬃﬃﬃﬃﬃ
N
p
.
Multiple markers — We examine the covariance between
the statistic Si at marker mi and Sj at marker mj given that SNP sc
is causal. Let ph
ij, ph
Ij, ph
iJ, ph
IJ be the haplotype frequencies with
minor and major alleles at mi and mj respectively, in the overall
population. Let pz
ij , pz
Ij , pz
iJ , pz
IJ and p{
ij , p{
Ij , p{
iJ , p{
IJ be the
frequencies in the case and control populations.
Collecting cases (or controls) is equivalent to drawing N
chromosomes from four possible haplotypes. Thus, the haplotype
count in cases, (N^ p pz
ij , N^ p pz
Ij , N^ p pz
iJ , N^ p pz
IJ), follows a multinomial
distribution. By the properties of the multinomial distribution,
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where rh
ij is the correlation coefficient between mi and mj
estimated from the reference dataset.
In practice, approximation in Formula (6) usually leads to an
accurate power estimate. However, if the relative risk is very large,
the Formula (5) can be computed exactly and used as follows. By
Formula (4), we can calculate pz
c and p{
c , the MAFs of the causal
SNP sc in the case and control populations. We can then estimate
pijc or pijC, the conditional probability that we will observe the
minor allele at mi given we observe the minor or major allele at sc.
Note that these conditional probabilities are exactly, not
approximately, invariant between cases and controls (See Text
S3). Therefore pz
i ~pijcpz
c zpijC 1{pz
c
  
. We can similarly
estimate p{
i and the haplotype frequencies (pz
ij and p{
ij ), which
allows us to compute Formula (5).
Let Sh~ Cov Si,Sj
     
be the M|M covariance matrix
between M markers. Let
Lc
ﬃﬃﬃﬃﬃ
N
p
~ l1,l2,...,lM ðÞ
ﬃﬃﬃﬃﬃ
N
p
~lc
ﬃﬃﬃﬃﬃ
N
p
rh
c1,rh
c2,...,rh
cM
  
ð7Þ
be the vector of NCPs induced by the causal SNP sc.B yt h e
multivariate central limit theorem [33], if N is large, the vector of
statistics (S1,...,SM) asymptotically follows a MVN with mean
Lc
ﬃﬃﬃﬃﬃ
N
p
and variance Sh.
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m. Given a
significance threshold a, ah
m is set to a level which controls the
outside-rectangle probability of the null MVN at a such that
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Given ah
m, the per-causal-SNP power with respect to a causal
SNP sc is the outside-rectangle probability of the alternative
MVN,
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as shown in Figure 2B. The average power is obtained by
averaging per-causal-SNP powers over all putative causal SNPs.
SLIP. Our method SLIP estimates the power of a study design
using the MVN framework. First, like SLIDE, SLIP estimates the
per-marker threshold in Formula (8) using a sliding window
approach. Then SLIP samples causal SNPs, approximates the
alternative MVN to estimate the per-causal-SNP power, and
averages per-causal-SNP powers over sampled causal SNPs.
Since power is typically larger (e.g. 80%) than a p-value (e.g.
.01), a small error in the per-marker threshold barely affects the
estimate. Thus, the error caused by using the asymptotic
approximation is negligible. Also, given a causal SNP, we can
assume that nearby markers (e.g. those within 61 Mb) can
capture most of the statistical power due to local LD. Thus, we can
set a window size and only use the markers within that window to
estimate the alternative MVN, which will be a n-dimensional
marginal MVN if we use n markers.
The computation becomes very efficient if we use approximation
(6).Sinceapproximation(6)statesthat thecovarianceisthesame for
the null and alternative MVNs, we can re-use the null MVN
constructedforestimating theper-marker threshold, byshiftingitby
the NCP to get the alternative MVN. If we re-use the random
samples this way, the constructed random samples will be not
completely random, as they depend on each other. However, we
observe that the inaccuracy caused by this dependency is negligible
if wegenerate a large numberofsamplesforthenullMVN. Ifwere-
use the samples, then with almost no additional computational cost,
SLIP can generate power estimates for multiple relative risks or
study sample sizes, since these only change the NCP.
Multiple Testing Correction Using Reference Dataset
Multiple testing correction is generally performed using the
collected data and not the reference data. Recall that the
difference between the per-marker threshold for multiple testing
correction (am) and the per-marker threshold for power estimation
(ah
m) is that the former is estimated from the collected data, the
latter from the reference data. We suggest that multiple testing can
be approximately corrected using the reference data, by using ah
m
as a substitute of am. The advantage is that we can obtain an idea
of the per-marker threshold even before the samples are collected.
In Results, we show the accuracy of this approximation using the
HapMap data and the WTCCC data.
Genotype Data
We downloaded the HapMap genotype data (release 23a, NCBI
build 36) from the HapMap project web site [14,38] and phased
the data into haplotypes using HAP [39], which can handle the
trio information. We downloaded the case/control genotype data
from the Wellcome Trust Case Control Consortium web site [11]
and phased it into haplotypes using Beagle [40].
Web Resources
The URL for methods presented herein is as follows: http://
slide.cs.ucla.edu
Results
Multiple Testing Correction
P-value correction in Chromosome 22 of WTCCC
data. In order to compare how accurately and efficiently
different methods correct multiple testing, we simulate a study
using the WTCCC data [11]. We use the chromosome 22 data
(5,563 SNPs) of the Type 2 diabetes (T2D) case/control study
(4,862 individuals). Since not every method can be applied to
unphased genotype data, we use haplotype data using the allelic x2
test and permutation by chromosomes. We first remove any
existing associations by randomly dividing the chromosomes into
half cases and half controls. Removing associations is necessary
because to correct a pointwise p-value, RAT currently requires an
actual SNP with that pointwise p-value to be implanted in the
dataset as the most significant SNP.
First, we perform 10 M permutations to correct ten different
pointwise p-values from 10
24 to 10
27, whose corrected p-values
are from .04 to .0004. We will consider the corrected p-values by
the permutation test as the gold standard, and call them permutation
p-values. We will assume a method is accurate if its corrected p-
values are close to the permutation p-values.
We use SLIDE, DSA, mvtnorm, RAT, and Keffective to
correct p-values. DSA and mvtnorm are MVN-based methods
using the block-wise strategy. We use a constant block size
(window size) of 100 markers for all methods. Since RAT defines
the window size in terms of physical distance, we use 600 kb, the
average distance of 100 markers in the dataset. We use -X -e2
option for RAT for an exact computation of the importance
sampling procedure as suggested by Kimmel and Shamir [30]. For
every method, we use a large number (.1 M) of sampling
iterations, which allows 95% confidence interval within 6.01p for
p~:04 and 6.1p for p~:0004. Keffective corrects p-values by
estimating the effective number of tests for a significance threshold
and dividing the pointwise p-values by that number. We use
a~:05 and window size of 100 for Keffective.
Figure 5 shows the ratios between the ten corrected p-values
and the permutation p-values. An accurate method will yield a
ratio of 1 for all ten different thresholds. The dashed lines denote
the area where an accurate method’s estimate will be found more
than 95% of the time. As expected, the Bonferroni correction is
very conservative, overestimating the p-values by 64% on average.
DSA is conservative with an average error of 19%. This is
equivalent to reducing the error by only about two thirds relative
to the Bonferroni correction. The reasons for the errors include
the block-wise strategy ignoring inter-block correlations, and not
correcting for the error caused by using the asymptotic
approximation. In addition to these errors, mvtnorm suffers from
an anti-conservative bias which grows as the p-value becomes
more significant. This is because the p-value in each block is too
small for mvtnorm to accurately estimate. Our simulation shows
that this anti-conservative bias increases with the number of
sampling iterations (data not shown).
Keffective is more accurate and faster than DSA and mvtnorm.
The average error of Keffective is 10.6%. Note that Keffective is
Multiple Testing Correction for Correlated Markers
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number of tests within ,10% of error. Thus, Keffective is
achieving its goal.
Both RAT and SLIDE show accurate estimates with the same
average error of 0.8%. Thus, the error rate of SLIDE’s corrected
p-values is more than 10 times smaller than the error rate of
Keffective’s corrected p-values, more than 20 times smaller than
the the error rate of DSA’s corrected p-values, and 80 times
smaller than the error rate of the Bonferroni-corrected p-values.
We now explore how each source of error in MVN-based
methods – the block-wise strategy and the use of the asymptotic
approximation without correction – affects the error rate. We
remove 1,048 rare SNPs (MAF,.05) and perform multiple testing
correction with respect to the remaining 4,515 common SNPs.
When considering only common SNPs, the error caused by using
the asymptotic approximation will be much smaller (See Materials
and Methods). Figure S1 shows that the average error of DSA is
reduced from 19% to 3.5%, showing that a considerable amount
of the error is due to using the asymptotic approximation without
correction. The error of Keffective is also reduced from 10.6% to
6.5%. The error of mvtnorm is increased from 9.4% to 12.9%
because the conservative error caused by using the asymptotic
approximation no longer compensates for its anti-conservative
bias. SLIDE and RAT are consistently accurate regardless of the
exclusion of rare SNPs. Although many methods look relatively
accurate when considering only common SNPs, they are
inaccurate when considering all SNPs.
Table 1 shows the extrapolated running time of each method
for correcting p-values with 500 K SNPs tested over 5,000
individuals. The running times of RAT, DSA, and mvtnorm
increases linearly with the number of p-values we correct, since
they are currently implemented to correct one p-value at a time
(though this may change in future versions). Since Keffective is not
a sampling approach, its running time is independent of the
number of samples. Given a window size of 100, our time estimate
for Keffective (19 h) is similar to the estimate (,20 h) in Moskvina
and Schmidt [6].
In many settings, SLIDE is 500 times faster than the
permutation test and considerably faster than the other methods.
The running time of SLIDE, Keffective, DSA, and mvtnorm is
approximately independent of the study sample size, whereas the
time of the permutation test is linearly dependent on it. Thus, the
efficiency gain of these methods relative to the permutation test
will increase as the study size increases. We summarize the
accuracy and efficiency of the tested methods in Figure 6.
Here we describe a few details of our running time
measurements. We used our own C implementation for the
permutation test. However, we expect that the measured time will
be similar to that for commonly used software such as PLINK [8],
based on the claimed running time of PLINK on its website (1
CPU-day for 50 k permutations over 100 K SNPs of 350 samples).
Note that PLINK’s default ‘‘adaptive permutation’’ is a single SNP
permutation to estimate the pointwise p-value, thus its max(T)
permutation is required for multiple testing correction. Measuring
the running time of mvtnorm has some subtleties since it has two
parameters, the number of samples (maxpts) and the absolute
error (abseps). The procedure is terminated if either the maximum
number of samples is reached or the specified error is obtained.
Therefore, we set abseps to a very small level (10
220) so that the
Figure 5. Ratios between corrected p-values and permutation
p-values for ten different p-value thresholds. We use the WTCCC
T2D case/control chromosome 22 data. Approximated time is for
correcting 10 p-values with respect to 500 K SNPs assuming 100 K
permutations. The dashed lines denote the interval where an accurate
methods’ estimate will be found more than 95% of the time.
doi:10.1371/journal.pgen.1000456.g005
Table 1. Running time for correcting genome-wide p-values in a study with 500 K SNPs over 5,000 individuals.
Procedure # Permutations Permutation SLIDE DSA Mvtnorm* RAT Keffective
Correcting 1 p-value 10 K 16 d 0.6 h 1.4 h 0.7 h 7 h 19 h
Correcting 10 p-values 10 K 16 d 0.6 h 14 h 7 h 70 h 19 h
Correcting 1 p-value 100 K 160 d 6 h 14 h 7 h 72 h 19 h
Correcting 10 p-values 100 K 160 d 6 h 140 h 70 h 30 d 19 h
Correcting 1 p-value 1 M 4 years 3 d 6 d 3 d 30 d 19 h
Correcting 10 p-values 1 M 4 years 3 d 60 d 30 d 300 d 19 h
*Often anti-conservative.
All values are extrapolated from the chromosome 22 results.
doi:10.1371/journal.pgen.1000456.t001
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some subtleties involving accuracy and efficiency. If we drop the -
X -e2 parameters for an approximated importance sampling,
RAT becomes much faster, but the resulting p-values are
underestimated by a factor of up to 5 (data not shown). We
assumed a corrected p-value of 10
24 to calculate the number of
iterations for RAT using the formula presented in Kimmel and
Shamir [30]. Since the formula is conservative, the running time of
RAT may be overestimated. The constant window size of 100 may
be too large for Keffective, since its purpose is to efficiently
approximate the estimate. With a window size of 10, Keffective
takes only 2 hours for 500 K SNPs. However, if we reduce the
window size, the time for other methods including SLIDE will also
be reduced.
Using the same WTCCC chromosome 22 dataset, we perform
an additional experiment for the unphased genotype data using
the trend test, assuming unbalanced case/controls. We find
SLIDE achieves similar accuracy (See Text S4 and Figure S2).
Per-marker threshold estimation using all SNPs in
HapMap. In this experiment, we assume that a single
threshold is being estimated to decide which findings to follow
up, instead of correcting each pointwise p-value. We estimate the
per-marker threshold corresponding to a significance threshold of
.05. We use the 2.7 million polymorphic SNPs in the HapMap
CEU data over the whole genome, instead of a single
chromosome.
We generate a simulated dataset using the phased haplotype
data of 60 HapMap CEU parental individuals. Specifically, we
create a new haplotype by randomly shuffling the 120 chromo-
somes so that the average length of a haplotype segment is
approximately 1 Mb. We mutate (flip) each SNP with probability
10
25. We create 2,000 cases and 2,000 controls by randomly
pairing 8,000 such haplotypes. Although this model is arbitrary, it
suffices to compare different methods. The results of the relative
comparison between methods do not greatly vary using different
parameters, such as a different average haplotype segment length
(data not shown).
We compare the permutation test, Keffective, and SLIDE.
RAT is not efficient for this setting because it is optimized for very
significant p-values, much smaller than .05. We expect that the
results of DSA or mvtnorm will be similar to or worse than those of
Keffective, as in the previous experiment.
We perform 10 K permutations for this experiment. We run
SLIDE with 10 K samplings and window size 100. We run
Keffective with window sizes 100 and 10. Figure 7 shows the
‘‘effective number of tests’’ estimated by each method, which is
simply the significance threshold (.05) divided by the estimated
per-marker threshold. The permutation test estimates the effective
number of tests as 1,068,746 out of 2,721,223 tests. Thus, the
Bonferroni correction is conservative by 155%. Note that in the
previous experiment with a less-dense SNP set, the Bonferroni
correction was conservative by 64%. The Bonferroni correction’s
error will continue to increase with the marker density.
The dashed lines denote the interval where an accurate
methods’ estimate will be found more than 95% of the time.
SLIDE estimates the effective number as 1,038,888 (2.8% error),
which is within the 95% interval. This small anti-conservative
error is only due to the stochastic error and not an inherent bias,
since the result becomes highly accurate as 1,068,445 (0.03%
error) if we increase the number of samples to 100 K.
Keffective estimates the effective number as 1,409,811 (32%
error) with window size 10 and as 1,252,986 (17% error) with
window size 100. Unlike the previous experiment, for this higher-
Figure 6. SLIDE’s accuracy and efficiency compared to other
methods. We use the WTCCC T2D case/control chromosome 22 data.
The vertical axis is the average error in corrected p-values relative to the
Bonferroni correction. The horizontal axis is the approximated time for
correcting 10 genome-wide p-values for 500 K SNPs assuming 100 K
permutations.
doi:10.1371/journal.pgen.1000456.g006
Figure 7. Effective number of tests of the 2.7 million HapMap
SNPs for a simulated dataset. A dataset of 2,000 cases and 2,000
controls is generated from the HapMap CEU data. Using each method,
we estimate the per-marker threshold corresponding to a significance
level of .05. The effective number of test is simply .05 divided by the
per-marker threshold. The dashed lines denote the interval where an
accurate methods’ estimate will be found more than 95% of the time.
doi:10.1371/journal.pgen.1000456.g007
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10%. We do not expect that a larger window size will increase the
accuracy of Keffective, because the error does not seem to be due
to the missing long range correlations, since SLIDE is accurate
with the same window size of 100.
The running time is 260 hours for permutation, 10 hours for
SLIDE, 10 hours for Keffective with window size 10, and
90 hours for Keffective with window size 100.
Window size. Since SLIDE takes into account only
correlations within the window size, here we investigate the
effect of window size on performance. A reasonable choice for the
window size will be the number of markers whose average distance
is the average or maximum LD distance in the data. For our
experiments, we use the WTCCC T2D case/control chromosome
22 dataset. A large number (10 M) of permutations allows us to
find that a pointwise p-value 1.53610
25 corresponds to the
corrected p-value .05. We correct this pointwise p-value using
SLIDE with various window sizes, and see if the corrected p-values
are close to .05.
Figure 8 shows the ratio between the corrected p-value and the
permutation p-value (.05) for various window sizes. Window size
zero denotes the Bonferroni correction. The estimate is within the
95% interval for window sizes greater than 20, showing that this is
the minimum choice of the window size for this dataset. In this
dataset, the average distance between 20, 50, and 100 markers are
approximately 100 Kb, 300 Kb, and 600 Kb.
Multiple testing correction using reference dataset. We
now examine whether the per-marker threshold estimated from
the reference dataset can approximate the true per-marker
threshold for a study which may have a different sample
correlation structure from the reference dataset. The marker set
we use is the SNPs in the Affymetrix 500 K chip over the whole
genome.
First, we apply SLIDE to the HapMap data using window size
100, to obtain the per-marker threshold 2.19610
27 corresponding
to the significance threshold .05. Then, we permute the WTCCC
data to estimate the false positive rate given this per-marker
threshold. We use the WTCCC 1958 British birth cohort control
data, which consists of 1,504 individuals. We randomly permute
the dataset 100 K times. We estimate the false positive rate, as the
proportion of permutations showing significance given the per-
marker threshold, to be .0508. Thus, in this experiment, the per-
marker threshold estimated from the reference data controls the
false positive rate with only 1.6% relative error. This result shows
that, even if the reference population and the target population are
slightly different (one from the Utah, U.S.A., and the other from
the Great Britain), the per-marker threshold estimated from the
reference data is a reasonable approximation.
Power Estimation
We compare four different methods for estimating genome-wide
power: standard simulation, null/alternative panel construction,
best-tag Bonferroni, and SLIP. We assume a multiplicative disease
model with a relative risk of 1.2 and a disease prevalence of .01,
and a significance threshold of .05. We use the CEU population
data in the HapMap as the reference dataset. We use the genome-
wide markers in the Affymetrix 500 K chip and assume a uniform
distribution of causal SNPs over all common SNPs (MAF$.05) in
the HapMap.
We first perform the standard simulation, which we will
consider as the gold standard. We construct a number of
genome-wide ‘alternative’ panels from the HapMap data by
randomly assigning a causal SNP for each panel. We permute
each panel 1,000 times to estimate the panel-specific per-marker
threshold. The power is estimated as the proportion of panels
showing significance given its per-marker threshold. Conneely and
Boehnke [4] used this procedure for power estimation.
Another panel construction-based approach is the null/
alternative panel construction method. Instead of permuting each
of alternative panels, this method constructs another set of ‘null’
panels under the null hypothesis. The null panel gives us a ‘global’
per-marker threshold that can be applied to all alternative panels.
Since this method is as accurate as the standard simulation but is
more efficient, it is widely used [17,18,21].
We apply SLIP and re-use the samples for the null MVN for
estimating the alternative MVNs. Lastly, we apply the analytical
best-tag Bonferroni method [19–21] which uses the Bonferroni
correction for the per-marker threshold and estimates power for
each causal SNP by using the most correlated marker (best tag
SNP). This method can also be accelerated by sampling the causal
SNPs and setting a window size.
For the standard simulation, we use 10 K alternative panels.
For the null/alternative panel construction method, we use 10 K
alternative panels and 10 k null panels. For SLIP, we use 10 K
sampling points. For the best-tag Bonferroni method, we use 10 K
samples for causal SNPs. For SLIP, we use a window size of 100
markers. For all other methods, we use a window size of 1 Mb.
Figure 9 shows that both SLIP and the null/alternative panel
construction method are as accurate as the standard simulation.
The best-tag Bonferroni method is inaccurate, underestimating
power by up to 5%.
Table 2 shows the running time of each method for estimating
genome-wide power. As shown, SLIP is very efficient. Since SLIP
uses the correlation structure, the running time is approximately
independent of the study sample size, whereas the running time of
the standard simulation or the null/alternative panel construction
method is linearly dependent on the sample size.
Discussion
SLIDE and SLIP provide efficient and accurate multiple testing
correction and power estimation in the MVN framework. SLIDE
shows a near identical accuracy to the permutation test by using a
Figure 8. Effect of window size on SLIDE’s performance. Using
the WTCCC T2D case/control chromosome 22 data, we plot the ratios
between the corrected p-value and the permutation p-value for varying
window sizes for SLIDE. We use the pointwise p-value corresponding to
the permutation p-value .05. The window size zero denotes the
Bonferroni correction. The dashed lines denote the interval where an
accurate methods’ estimate will be found more than 95% of the time.
doi:10.1371/journal.pgen.1000456.g008
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correcting for the error caused by using the asymptotic
approximation. SLIDE can be applied to datasets of millions of
markers with many rare SNPs, while other MVN-based methods
become inaccurate as more rare SNPs are included. To the best of
our knowledge, SLIP is the first MVN-based power estimation
method.
Throughout this paper, we considered the classical multiple
testing correction controlling family-wise error rate (FWER) [7], the
probability of observing one or more false positives. SLIDE can be
extended to control false discovery rate [41,42] as well, using a
similar approach to Lin [10]. In Text S1, we show that the MVN
framework can be extended to the weighted haplotype test [15,16]
and the test for imputed genotypes [17]. SLIDE can be use for any
multiple testing correction problem with a local correlation
structure,aslongasthecovariancebetweenstatisticscanbederived.
We considered the permutation test as the gold standard for
multiple testing correction. The permutation test can be
performed in two different ways: at each permutation, we can
either assess the maximum statistics among the markers (max-T
permutation), or assess the minimum pointwise p-value among the
markers by performing another permutation for each marker
(min-P permutation) [7,42]. We used the former approach because
the latter approach is computationally very intensive.
In Text S5 and Figure S3, we describe some additional insights
obtained through the study. When marker frequencies do not
follow the Hardy-Weinberg proportions (HWP), the use of an
allelic test (e.g. allelic x2 test) for unphased genotype data is not
recommended due to the possible bias [43]. However, widely used
software [8] often allows the use of an allelic test for genotype data
under the reasoning that, as long as the permutation or an exact
test is performed, the pointwise p-value will be the same as if we
use a genotypic test (e.g. Armitage’s trend test). Theoretically, this
is due to the fact that the allelic and genotypic test statistics differ
only by their variance [44]. However, for assessing corrected p-
values, the permutation test does not provide this kind of
‘‘protection’’. Even after a quality control process that excludes
SNPs which significantly deviate from the Hardy-Weinberg
equilibrium (HWE), still many SNPs may not follow HWP.
Therefore, using an allelic test for genotype data for multiple
testing correction can result in inaccurate estimates.
Recently, a different view of multiple testing correction has been
introduced [5,28], which suggest that we should correct for the
uncollected or unknown markers as well as the collected markers,
in order to take into account additional testing burdens such as the
possible testings in a follow-up study. Pe’er et al. [28] estimates the
per-marker threshold by extrapolating from the resequenced
ENCODE regions, and Dudbridge et al. [5] estimates the per-
marker threshold by subsampling the SNPs at an increasing SNP
density. Although we employed the classical point of view that
corrects for multiple testing only over observed SNPs, our method
can also be applied to this alternative view. Our method can be
used to estimate the effective number of tests for a representative
resequenced region or for the set of subsampled SNPs. Since the
SNP density of genotyping technology is dramatically increasing,
we assume that the number of unknown and uncollected SNPs will
decrease, causing the two different views to converge.
In our experiments, we used a constant block size for the block-
wise strategy. In practice, it will be more reasonable to split the
region according to the LD blocks. However, this is not always
possible because LD blocks are often ambiguous and some blocks
can be larger than the maximum block size of the method. For
example, if we collect 10 million SNPs, a block size of 1,000 is
required to cover 300 kb LD. However, the maximum block size
of mvtnorm that allows an accurate estimate is currently 300 [4],
and DSA with window size 1,000 often requires a prohibitively
large memory in our simulations (data not shown). By contrast,
SLIDE with window size 1,000 for the WTCCC chromosome 22
data requires ,150 Mb memory and thus is feasible. Nevertheless,
it should be noted that the block-wise strategy can always be
implemented to have the same block size as SLIDE.
Recently, a method called PRESTO [45] was introduced,
which increases the efficiency of the permutation test by applying
Figure 9. Genome-wide power of the Affymetrix 500 k chip
estimated by different methods. We use the HapMap CEU
reference data. We assume a multiplicative disease model with relative
risk 1.2, disease prevalence .01, and a uniform distribution of causal
SNPs over common SNPs (MAF$.05). We use the significance threshold
of .05.
doi:10.1371/journal.pgen.1000456.g009
Table 2. Running time for estimating genome-wide power with 10 K samplings.
Procedure #cases/controls Best-tag-Bonf.* SLIP Null/altern. Std. simul.
Estimating power 1,000/1,000 0.1 h 0.6 h 36 h 10 d
5,000/5,000 0.1 h 0.6 h 8 d 50 d
Estimating power for 5 different relative risks 1,000/1,000 0.1 h 0.6 h 8 d 50 d
5,000/5,000 0.1 h 0.6 h 40 d 250 d
*Inaccurate (average error is not within 1%).
doi:10.1371/journal.pgen.1000456.t002
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time, SLIDE is ,10 times faster than PRESTO, but PRESTO has
an advantage that it does not depend on the asymptotic
approximation but provides exactly the same result as the
permutation test.
We considered the pairwise correlation between SNPs. There
can also be so-called higher-order correlations, such as the
correlation between a haplotype and a SNP. For example, even
though three SNPs are pairwisely independent, the combination of
the first two SNPs can be a perfect proxy to the third SNP.
However, the multivariate central limit theorem proves that the
joint distribution of the test statistics is fully characterized by the
matrix of the pairwise correlations. Thus, the effect of the other
correlation terms on the joint distribution is asymptotically
negligible. Nevertheless, our method is not limited to the SNP
test. If our method is applied to the weighted haplotype test
[15,16] as shown in Text S1, the pairwise correlation in the
correlation matrix can be interpreted as the higher-order
correlations between a haplotype and a SNP or between
haplotypes.
In summary, SLIP and SLIDE are two useful methods for
genome-wide association studies which provide accurate power
estimation at the design step and accurate multiple testing
correction at the analysis step. The software is available as a
resource for the research community.
Supporting Information
Figure S1 Ratios between the corrected p-values and permuta-
tion p-values after rare SNPs are removed. We use the
chromosome 22 of the WTCCC Type 2 diabetes cases/controls
data. Multiple testing is corrected with respect to the 4,515
common SNPs (MAF$.05).
Found at: doi:10.1371/journal.pgen.1000456.s001 (0.01 MB PDF)
Figure S2 Ratios between the corrected p-values and permuta-
tion p-values for genotype data. We simulate a unphased genotype
dataset using the chromosome 22 data of the WTCCC Type 2
diabetes cases/controls data, assuming a unbalanced study of
2,934 controls and 1,928 cases.
Found at: doi:10.1371/journal.pgen.1000456.s002 (0.01 MB PDF)
Figure S3 Inaccurate multiple testing correction caused by the
use of an allelic test for unphased genotype data. We generate a
simulated unphased genotype data of 120 cases and 120 controls
from the HapMap CEU population chromosome 22 data. Then
we plot the ratios between the corrected p-values by two different
permutations: permutation test using the allelic test statistic, and
permutation test using the genotypic test statistic. Quality control
is performed by the standard x
2 test for HWE.
Found at: doi:10.1371/journal.pgen.1000456.s003 (0.01 MB PDF)
Text S1 Rapid and accurate multiple testing correction and
power estimation for millions of correlated markers.
Found at: doi:10.1371/journal.pgen.1000456.s004 (0.14 MB PDF)
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